LCI 1461 (Dipyridamole 25 mg)

Pill imprint LCI 1461 has been identified as Dipyridamole 25 mg.

Dipyridamole is used in the treatment of radionuclide myocardial perfusion study; prosthetic heart valves - thrombosis prophylaxis and belongs to the drug classes cardiac stressing agents, platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Dipyridamole 25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Dipyridamole

Imprint:

LCI 1461

Strength:

25 mg

Color:

Orange

Shape:

Round

Availability:

Prescription only

Drug Class:

Cardiac stressing agents
Platelet aggregation inhibitors

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Lannett Company, Inc.

National Drug Code (NDC):

00527-1461

Inactive Ingredients:

microcrystalline cellulose
povidone k29/32
crospovidone
lactose monohydrate
silicon dioxide colloidal
magnesium stearate
FD&C Red No. 40
FD&C Yellow No. 6
soya lecithin
polyethylene glycol
polyvinyl alcohol
magnesium silicate
titanium dioxide
aluminum oxide

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
10135-0536	Marlex Pharmaceuticals Inc

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.